Literature DB >> 19141447

Histopathology and growth kinetics of influenza viruses (H1N1 and H3N2) in the upper and lower airways of guinea pigs.

Xuehui Tang1, Kong T Chong2,1.   

Abstract

Recent investigations have shown that guinea pigs are important for the study of influenza A virus (IAV) transmission. However, very little is known about IAV replication and histopathology in the guinea pig respiratory tract. Here, we describe viral growth kinetics, target cells and histopathology in the nasosinus, trachea and lungs of IAV-infected guinea pigs. We found that guinea pigs infected with either A/Puerto Rico/8/34 (H1N1) or A/Hong Kong/8/68 (H3N2) developed a predominantly upper airway infection with high nasal viral titres. IAV grew to moderate titres in the lungs but induced marked inflammatory responses, resulting in severe bronchopneumonia and alveolitis. Although non-lethal at the high dose of 2x10(6) p.f.u., infections with these IAV strains were associated with reduced weight gain. IAV infection in guinea pigs is characterized by extensive viral replication in the ciliated nasal epithelial cells followed by heavy nasal mucus secretion.

Entities:  

Mesh:

Year:  2009        PMID: 19141447     DOI: 10.1099/vir.0.007054-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus.

Authors:  Fengyun Ni; Innocent Nnadi Mbawuike; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

Review 2.  Influenza A virus infection kinetics: quantitative data and models.

Authors:  Amber M Smith; Alan S Perelson
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

3.  Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses.

Authors:  Yipeng Sun; Yuhai Bi; Juan Pu; Yanxin Hu; Jingjing Wang; Huijie Gao; Linqing Liu; Qi Xu; Yuanyuan Tan; Mengda Liu; Xin Guo; Hanchun Yang; Jinhua Liu
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

4.  Animal Models for Influenza Virus Pathogenesis and Transmission.

Authors:  Nicole M Bouvier; Anice C Lowen
Journal:  Viruses       Date:  2010       Impact factor: 5.048

5.  A comprehensive breath plume model for disease transmission via expiratory aerosols.

Authors:  Siobhan K Halloran; Anthony S Wexler; William D Ristenpart
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

6.  Infection of novel reassortant H1N2 and H3N2 swine influenza A viruses in the guinea pig model.

Authors:  Rodrigo Tapia; Victoria García; Juan Mena; Sergio Bucarey; Rafael A Medina; Víctor Neira
Journal:  Vet Res       Date:  2018-07-27       Impact factor: 3.683

Review 7.  Animal models for influenza virus pathogenesis, transmission, and immunology.

Authors:  Rajagowthamee R Thangavel; Nicole M Bouvier
Journal:  J Immunol Methods       Date:  2014-04-04       Impact factor: 2.303

8.  Pathology of Equine Influenza virus (H3N8) in Murine Model.

Authors:  Selvaraj Pavulraj; Bidhan Chandra Bera; Alok Joshi; Taruna Anand; Meenakshi Virmani; Rajesh Kumar Vaid; Karuppusamy Shanmugasundaram; Baldev Raj Gulati; K Rajukumar; Rajendra Singh; Jyoti Misri; Raj Kumar Singh; Bhupendra Nath Tripathi; Nitin Virmani
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

Review 9.  Transmission in the guinea pig model.

Authors:  Anice C Lowen; Nicole M Bouvier; John Steel
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

10.  Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model.

Authors:  Jon D Gabbard; Daniel Dlugolenski; Debby Van Riel; Nicolle Marshall; Summer E Galloway; Elizabeth W Howerth; Patricia J Campbell; Cheryl Jones; Scott Johnson; Lauren Byrd-Leotis; David A Steinhauer; Thijs Kuiken; S Mark Tompkins; Ralph Tripp; Anice C Lowen; John Steel
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.